Pancreatic Cancer Research

ResearcherXijing HospitalActive in the last 2 years

Shuqiang Yue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0026-6522; OpenAlex author ID A5040641217. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Identification of mitochondrial-related subtypes and development of a prognostic model for pancreatic ductal adenocarcinoma. Last author DOI 10.21037/jgo-2025-613↗
  2. EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.bbadis.2024.167336↗
  3. Application of Nanoparticles in Diagnosis and Treatment of Pancreatic Cancer. Co-author DOI 10.1155/2022/7803001↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juzheng Yuan · 2 shared papers, 2022–2024 · strength 0.41
  2. Desheng Wang · 1 shared paper, 2026 · strength 0.39
  3. Fen Zhang · 1 shared paper, 2026 · strength 0.39
  4. Fuyuan Liu · 1 shared paper, 2024 · strength 0.21
  5. Xiao Li · 1 shared paper, 2024 · strength 0.21
  6. Xiao Li · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.